Queen Sirikit National Institute of Child Health
11
0
0
6
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
Moderate Risk
Score: 35/100
0.0%
0 terminated/withdrawn out of 11 trials
100.0%
+13.5% vs industry average
18%
2 trials in Phase 3/4
33%
2 of 6 completed trials have results
Key Signals
Enrollment Performance
Analytics
Activity Timeline
Global Presence
Clinical Trials (11)
The Transcriptomic Study of Thai Patients With Atopic Dermatitis by Tape Strips
Role: lead
Single Dose of Clonazepam Versus Intermiittent Diazepam for Febrile Seizures Prevention
Role: lead
Posterior Quadratus Lumborum Block Using 0.125% Versus 0.25% Bupivacaine for Analgesia in Children Undergoing LPEC
Role: lead
Vitamin D Supplementation During Lactation
Role: collaborator
Bacterial Transmission Dynamics Study
Role: collaborator
Effect of Folic Acid Supplementation on Plasma Homocysteine Level in Obese Children
Role: lead
Pediatric Study for Appropriate Dose of Ritonavir Boosted Lopinavir in Thai HIV-infected Children (PEARL)
Role: collaborator
Compare Efficacy Nebulized and Intravenous Magnesium Sulphate in Thai Children
Role: lead
Human Papillomatosis Genotyping of Children in Thailand
Role: lead
Immunogenicity and Reactogenicity of a Trivalent MMR (Trivivac) in Healthy Infants
Role: lead
Improving Latent Tuberculosis (TB) Diagnosis in Thai Children
Role: collaborator
All 11 trials loaded